Copyright
©The Author(s) 2022.
World J Gastroenterol. Jun 28, 2022; 28(24): 2705-2732
Published online Jun 28, 2022. doi: 10.3748/wjg.v28.i24.2705
Published online Jun 28, 2022. doi: 10.3748/wjg.v28.i24.2705
Table 2 Clinicopathological features of the early-stage colon cancer patients enrolled in this study, n (%)
Variable | Total (n = 125) | Training set (n = 75) | Test set (n = 50) |
Age (yr) | 69 (range, 48-94) | 68 (range, 51-94) | 70 (range, 48-88) |
Sex | |||
Male | 66 (52.8) | 39 (52.0) | 27 (54.0) |
Female | 59 (47.2) | 36 (48.0) | 23 (46.0) |
Serum CEA (≥ 5 ng/mL) | |||
Positive | 37 (29.6) | 21 (28.0) | 16 (32.0) |
Negative | 88 (70.4) | 54 (72.0) | 34 (68.0) |
FIT (≥ 200 ng/mL) | |||
Positive | 78 (62.4) | 48 (64.0) | 30 (60.0) |
Negative | 47 (37.6) | 27 (36.0) | 20 (40.0) |
Tumor site | |||
Proximal | 64 (51.2) | 36 (48.0) | 28 (56.0) |
Distal | 61 (48.8) | 39 (52.0) | 22 (44.0) |
TNM stage | |||
I | 47 (37.6) | 30 (40.0) | 17 (34.0) |
II | 78 (62.4) | 45 (60.0) | 33 (66.0) |
T stage | |||
T1-3 | 71 (56.8) | 44 (58.7) | 27 (54.0) |
T4 | 54 (43.2) | 31 (41.3) | 23 (46.0) |
Histological differentiation | |||
Well/moderately | 98 (78.4) | 60 (80.0) | 38 (76.0) |
Poorly | 27 (21.6) | 15 (20.0) | 12 (24.0) |
- Citation: Jiang HH, Xing SW, Tang X, Chen Y, Lin K, He LW, Lin MB, Tang EJ. Novel multiplex stool-based assay for the detection of early-stage colon cancer in a Chinese population. World J Gastroenterol 2022; 28(24): 2705-2732
- URL: https://www.wjgnet.com/1007-9327/full/v28/i24/2705.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i24.2705